Cas9

Cas9

Microbial protein found in streptococcus pyogenes m1 gas

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Angus Liu
July 16, 2020
FierceBiotech
It's difficult to deliver CRISPR-Cas gene-editing system into cells efficiently because of the package's large size. But now, a University of California, Berkeley, team led by CRISPR pioneer Jennifer Doudna has identified a "hypercompact" CRISPR enzyme, Cas Φ, which boasts several advantages over existing options.
January 30, 2020
WebWire
Mammoth Biosciences, the company behind the world's first CRISPR-based disease detection platform, today announced an oversubscribed round of $45 million in its Series B. The raise is led by Decheng Capital and has participation from Mayfield, NFX, Verily, Brook Byers, Plum Alley, Pacific 8, aMoon, and others. The capital will fuel the company's further development of CRISPR diagnostics and next-generation CRISPR products as it extends its platform to include gene-editing and therapeutics...
Michael Le Page
Invalid Date
New Scientist
A new variant of CRISPR, dubbed prime editing, should make it even better at correcting disease-causing mutations
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.